Citable company snapshot
Johnson & Johnson's latest SEC-sourced 2026-03-29 period shows $24.06B in revenue and $5.24B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:RevenueFromContractWithCustomerExcludingAssessedTax | Mar 29, 2026 | $24.06B | $24.56B | -2.0% |
| xbrl:GrossProfit | Mar 29, 2026 | $15.96B | $16.60B | -3.9% |
| xbrl:OperatingIncomeLoss | Mar 29, 2015 | $5.83B | $3.01B | +93.5% |
| xbrl:NetIncomeLoss | Mar 29, 2026 | $5.24B | $5.12B | +2.3% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 29, 2026 | $2.51B | $7.31B | -65.6% |
| Free Cash Flow (computed) | Mar 29, 2026 | $1.47B | $5.47B | -73.2% |
Source: SEC EDGAR XBRL; period Mar 29, 2026; filed Apr 22, 2026; accession 0000200406-26-000087.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
